Nanoparticle Exposure Linked To Rheumatoid Arthritis And Other Autoimmune Diseases

  • Sharebar

Editor’s Choice
Academic Journal
Main Category: Arthritis / Rheumatology
Also Included In: Immune System / Vaccines
Article Date: 18 Jun 2012 – 7:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

<!– rate icon rate article



Patient / Public:4 stars

4 (1 votes)

Healthcare Prof:not yet rated


According to a study published in the journal Nanomedicine, researchers have found an association between exposure to nanoparticles and rheumatoid arthritis and the development of other serious autoimmune disease. In addition, the team discovered new cellular targets for developing potential drug therapies to treat autoimmune diseases.

Findings from the study, conducted by researchers at Trinity College Dublin, indicate that there are health and safety implications for the manufacture, utilization, and disposal of nanotechnology products and materials.

Smoking, carbon particles emitted by car exhaust, and inhalation of dust over the long-term are all risk factors which cause chronic inflammation of the lungs. In addition, researchers have also established an association between smoking and autoimmune diseases, such as rheumatoid arthritis.

In this study, the authors identified similar risks cause by nanotechnology products, which may produce new types of airborne pollutants that can impact global health if not handled appropriately.

In order to determine whether there was a common underlying mechanism contributing to the development of autoimmune diseases in human cells when exposed to nanoparticles, Professor of Molecular Medicine Yuri Volkov and his Nanomedicine and Molecular Imaging team at Trinity College Dublin’s School of Medicine, applied a wide range of nanomaterials to human cells derived from the lining of the airway passages, and to so-called phagocytic origin – cells that are more exposed to inhaled foreign particles or are responsible with eliminating them from the body.

The nanomaterials involved included, carbon nanotubes, ultrafine carbon black, and silicon dioxide particles of different sizes, ranging from 20 to 400 nanometers.

Amino acid transforms, triggering autoimmune disease

Meanwhile, scientists from the Health Effects Laboratory Division, National Institute for Occupational Safety Health, Morgantown, WV, USA, conduced studies on mice exposed to long term inhalation of air contaminated with single walled carbon nanotubes.

In both the TCD and US study, the researchers found that all types of nanoparticles caused an identical response in the lungs of mice and in human cells, resulting in the specific transformation of the amino acid arginine into the citrulline molecule, which can trigger autoimmune diseases.

Human proteins which incorporate citrulline are unable to function normally and are destroyed and disposed of by the body’s defense system. Once citrullinated proteins are eliminated, the immune system begins to attack its own organs and tissues, thus causing the development of autoimmune diseases.

Professor Volkov explained:

“The research establishes a clear link between autoimmune diseases and nanoparticles. Preventing or interfering with the resulting citrullination process looks therefore as a promising target for the development of future preventative and therapeutic approaches in rheumatoid arthritis and possible other autoimmune conditions.”

Written by Grace Rattue

Copyright: Medical News Today

Not to be reproduced without permission of Medical News Today

  • Additional
  • References
  • Citations

Please use one of the following formats to cite this article in your essay, paper or report:

MLA


APA


Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

‘Nanoparticle Exposure Linked To Rheumatoid Arthritis And Other Autoimmune Diseases’

Please note that we publish your name, but we do not publish your email address. It is only used to let
you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care
professional. For more information, please read our terms and conditions.

MediLexicon International Ltd Logo

Privacy Policy |
Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Everyday Health Network

back to top | home |
privacy policy

MediLexicon International Ltd Logo

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Comments are closed.